Lemtrada's Benefits Can Help Multiple Sclerosis Patients Where Others Have Failed

Video

In a longterm condition like multiple sclerosis finding the proper treatment option can often be a difficult task. A medication was recently approved to help patients who have struggled to find that help in the past.

In a longterm condition like multiple sclerosis finding the proper treatment option can often be a difficult task. A medication was recently approved to help patients who have struggled to find that help in the past.

Ann Bass, MD, from the Neurology Center of San Antonio discussed the advantages and potential risks of the medication at the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers in Indianapolis. Bass said the medication is given in two stages over the course of two years and many patients do not need a third dose after that making it an attractive option.

Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA
Joel Gelfand, MD, MSCE: Phototherapy Utility in Psoriasis
Pediatric Hidradenitis Suppurativa Severity not Linked to Obesity
Rizankizumab and the KNOCKOUT Study, with Andrew Blauvelt, MD, MBA
© 2024 MJH Life Sciences

All rights reserved.